hTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-κB signaling pathway
Open Access
- 6 March 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (16) , 26969-26978
Abstract
HTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-κB signaling pathwayKeywords
This publication has 57 references indexed in Scilit:
- Telomerase directly regulates NF-κB-dependent transcriptionNature Cell Biology, 2012
- Gastric intestinal metaplasia revisited: function and regulation of CDX2Trends in Molecular Medicine, 2012
- Cdx2 determines the fate of postnatal intestinal endodermDevelopment, 2012
- CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotypeGut, 2010
- Relapse of renal cell carcinoma with disappearance of HLA class I following hTERT peptide vaccinationAnnals of Oncology, 2010
- Inhibiting NF-κB activation by small molecules as a therapeutic strategyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Prognostic Significance of Telomerase Polymorphism in Non–Small Cell Lung CancerClinical Cancer Research, 2010
- Acid and Bile Salt–Induced CDX2 Expression Differs in Esophageal Squamous Cells From Patients With and Without Barrett's EsophagusGastroenterology, 2010
- Cdx2 homeodomain protein regulates the expression of MOK, a member of the mitogen‐activated protein kinase superfamily, in the intestinal epithelial cellsFEBS Letters, 2004
- MUC1 polymorphism confers increased risk for intestinal metaplasia in a Colombian population with chronic gastritisEuropean Journal of Human Genetics, 2003